Moderna publishes interim results from older adults in phase 1 study of its COVID-19 vaccine Read more
Serum Institute to produce up to additional 100 mn COVID-19 vaccine doses for India and LMIC in 2021 Read more
Pfizer get USFDA nod for XELJANZ (tofacitinib) to treat active polyarticular course juvenile idiopathic arthritis Read more